Safety and biomarker assessment of ST316, a novel peptide antagonist of ß-catenin, in patients with advanced solid tumors.

Authors: Anthony B. El-Khoueiry, Nehal J. Lakhani, Jason Timothy Henry, Steven Francis Powell, Niharika B. Mettu, Joyce Gakuria, Franco Abbate, Paolo Nuciforo, Jim Rotolo, Abi Vainstein Haras

Published: 2025-01-27

DOI: 10.1200/jco.2025.43.4_suppl.286

Source: Full article


Abstract

286